Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect and Mass Balance of SHR3824 in Healthy Volunteers
NCT02353975Phase 1Completed
- Sponsor
- Hengrui
- Start
- May 2014
- Primary completion
- Jul 2014
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of henagliflozin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Hengrui. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve and 1 more. Started May 2014; status: completed.
02
Drugs
henagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02353975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02353975.